1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Infusion Systems Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Infusion Systems Market, North America
3.1 Infusion Systems Market, North America, Revenue ($m), 2018-2033
3.2 Infusion Systems Market, North America, Revenue ($m), 2018-2033
3.3 Infusion Systems Market, North America, Volume (Units), 2018-2033
3.4 Infusion Systems Market, North America, Volume (Units), 2018-2033
3.5 Infusion Systems Market, North America, Company Share by Revenue ($m), 2025
4 Infusion Systems Market, Canada
4.1 Infusion Systems Market, Canada, Revenue ($m), 2018-2033
4.1.1 Infusion Pump Disposables Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.2 Infusion Pumps Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Infusion Systems Market, Canada, Volume (Units), 2018-2033
4.2.1 Infusion Pump Disposables Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.2 Infusion Pumps Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Infusion Systems Market, Canada, Average Price ($), 2018-2033
4.4 Infusion Systems Market, Canada, Company Share by Revenue ($m), 2025
5 Infusion Systems Market, Mexico
5.1 Infusion Systems Market, Mexico, Revenue ($m), 2018-2033
5.1.1 Infusion Pump Disposables Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.2 Infusion Pumps Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Infusion Systems Market, Mexico, Volume (Units), 2018-2033
5.2.1 Infusion Pump Disposables Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.2 Infusion Pumps Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Infusion Systems Market, Mexico, Average Price ($), 2018-2033
5.4 Infusion Systems Market, Mexico, Company Share by Revenue ($m), 2025
6 Infusion Systems Market, United States
6.1 Infusion Systems Market, United States, Revenue ($m), 2018-2033
6.1.1 Infusion Pump Disposables Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.2 Infusion Pumps Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Infusion Systems Market, United States, Volume (Units), 2018-2033
6.2.1 Infusion Pump Disposables Market, United States, Volume (Units), by Segment, 2018-2033
6.2.2 Infusion Pumps Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Infusion Systems Market, United States, Average Price ($), 2018-2033
6.4 Infusion Systems Market, United States, Company Share by Revenue ($m), 2025
7 Overview of Key Companies in North America Infusion Systems Market
7.1 B. Braun Melsungen AG
7.1.1 Company Overview
7.2 Becton Dickinson and Co
7.2.1 Company Overview
7.3 ICU Medical Inc
7.3.1 Company Overview
7.4 Baxter International Inc
7.4.1 Company Overview
7.5 Smiths Medical
7.5.1 Company Overview
7.6 B. Braun Medical Inc
7.6.1 Company Overview
8 Infusion Systems Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Nov 24, 2025: SEHA and PureHealth Introduce CyberKnife Technology at Tawam Hospital, First in UAE
9.1.2 Nov 19, 2025: RenovoRx CEO Shaun Bagai to Present at Alliance Global Partners Virtual Showcase
9.1.3 Nov 18, 2025: TriSalus Life Sciences Launches TriNav XP Infusion System for Drug Delivery
9.1.4 Oct 30, 2025: Edwards Lifesciences CFO Transition Plan Announced
9.1.5 Oct 30, 2025: EZBio Viper Needles for Aseptic Fill-Finish Operations
9.1.6 Oct 27, 2025: Vivos Inc. Appoints Dr. John J. Smith as FDA Regulatory Advisor for RadioGel IDE Submission
9.1.7 Oct 21, 2025: IU Breaks Ground on IU Launch Accelerator for Biosciences
9.1.8 Oct 15, 2025: Northumbria University Secures Additional Funding for Blood Flow Restriction Technology Research in Space
9.1.9 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme
9.1.10 Sep 25, 2025: Lucid Diagnostics Appoints John R. Palumbo to Board of Directors
9.1.11 Sep 12, 2025: Developing Personalized Cell Therapies To Cure Disease
9.1.12 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
9.1.13 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
9.2 Financial Announcements
9.2.1 Feb 04, 2026: IRADIMED CORPORATION to Hold Fourth Quarter and Full-Year 2025 Financial Results Conference Call
9.2.2 Feb 03, 2026: Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
9.2.3 Nov 03, 2025: Iradimed Reports Record Third Quarter 2025 Financial Results
9.2.4 Oct 23, 2025: Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
9.2.5 Oct 22, 2025: KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
9.2.6 Oct 02, 2025: AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results
9.2.7 Aug 14, 2025: PAVmed Announces Business Update and Posts Q2 2025 Results
9.2.8 Aug 01, 2025: iRadimed Announces Q2 2025 Results
9.2.9 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
9.2.10 Jul 16, 2025: KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025
9.2.11 Mar 19, 2025: AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event
9.3 Government and Public Interest
9.3.1 Feb 23, 2026: AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
9.3.2 Dec 22, 2025: AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
9.3.3 Nov 19, 2025: RenovoRx CEO Shaun Bagai to Present at Alliance Global Partners Virtual Showcase
9.3.4 Nov 13, 2025: KORU Medical Systems to Participate in Upcoming Investor Conferences
9.3.5 Nov 11, 2025: TriSalus Life Sciences to Participate in Upcoming Investor Conferences
9.3.6 Oct 27, 2025: AngioDynamics to Participate in the UBS Global Healthcare Conference
9.3.7 Jul 30, 2025: KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
9.4 Other Significant Developments
9.4.1 Nov 19, 2025: RenovoRx CEO Shaun Bagai to Present at Alliance Global Partners Virtual Showcase
9.4.2 Nov 13, 2025: Duncan Regional Hospital First in U.S. to Implement BD Alaris EMR Infusion Interoperability with MEDITECH
9.4.3 Oct 30, 2025: Clarity Pharmaceuticals and Nusano Sign Medical Isotopes Supply Agreement
9.4.4 Oct 15, 2025: Northumbria University Secures Additional Funding for Blood Flow Restriction Technology Research in Space
9.4.5 Sep 25, 2025: Global Technology Manufacturer Chooses Kneat for Digital Transformation
9.5 Product News
9.5.1 Feb 24, 2026: TremeBio Launches Lymphatic-Targeting Drug Delivery Platform
9.5.2 Nov 17, 2025: Future of AI in Infusion Therapy — Health Line Medical Products
9.5.3 Nov 13, 2025: Flex And Merck KGaA, Darmstadt, Germany, Win 2025 PDA Drug Delivery Innovation Award
9.5.4 Nov 13, 2025: Duncan Regional Hospital First in U.S. to Implement BD Alaris EMR Infusion Interoperability with MEDITECH
9.5.5 Nov 04, 2025: Koru Medical Systems Announces Development Agreement for Subcutaneous Immunoglobulin Infusion Systems
9.5.6 Oct 27, 2025: Incyte and Enable Injections Form Strategic Partnership for enFuse On-Body Delivery System
9.5.7 Oct 27, 2025: Vivos Inc. Appoints Dr. John J. Smith as FDA Regulatory Advisor for RadioGel IDE Submission
9.5.8 Oct 10, 2025: An International Project Employs 'Resurrected' Ancestral Enzymes for Cancer Prevention and Neurobiology Studies
9.5.9 Oct 01, 2025: Niagen Bioscience's Niagen IV and Injections Available at Over 50 iCRYO Clinics Nationwide
9.5.10 Sep 18, 2025: ForCast Orthopedics And KORU Medical Systems Announce Agreement For Novel Antibiotic Infusion Therapy
9.5.11 Sep 12, 2025: BD Updates Recall Of Certain Alaris Pump Infusion Sets
9.5.12 Sep 10, 2025: UK Startups Collaborate With TMC to Innovate in Patient Safety, Maternal Health, Trauma, Neurology, and Surgery
9.5.13 Sep 08, 2025: Anixa and Moffitt Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
9.5.14 Jun 16, 2025: GI Windows Surgical Receives U.S. Food and Drug Administration Clearance for Flexagon
9.5.15 Apr 04, 2025: MedLearn Launches DrugCode Pro
9.6 Research And Development
9.6.1 Oct 15, 2025: Northumbria University Secures Additional Funding for Blood Flow Restriction Technology Research in Space
9.6.2 Oct 10, 2025: An International Project Employs 'Resurrected' Ancestral Enzymes for Cancer Prevention and Neurobiology Studies
9.6.3 Sep 12, 2025: Developing Personalized Cell Therapies To Cure Disease
9.7 Strategy And Business Planning
9.7.1 Nov 04, 2025: Koru Medical Systems Announces Development Agreement for Subcutaneous Immunoglobulin Infusion Systems
9.7.2 Oct 30, 2025: Clarity Pharmaceuticals and Nusano Sign Medical Isotopes Supply Agreement
9.7.3 Oct 27, 2025: Incyte and Enable Injections Form Strategic Partnership for enFuse On-Body Delivery System
9.7.4 Oct 21, 2025: IU Breaks Ground on IU Launch Accelerator for Biosciences
9.7.5 Oct 01, 2025: Niagen Bioscience's Niagen IV and Injections Available at Over 50 iCRYO Clinics Nationwide
9.7.6 Sep 25, 2025: Global Technology Manufacturer Chooses Kneat for Digital Transformation
9.7.7 Sep 18, 2025: ForCast Orthopedics And KORU Medical Systems Announce Agreement For Novel Antibiotic Infusion Therapy
9.7.8 Sep 10, 2025: UK Startups Collaborate With TMC to Innovate in Patient Safety, Maternal Health, Trauma, Neurology, and Surgery
9.7.9 Sep 03, 2025: Northwestern Medicine Opens New Outpatient Center in Bronzeville
9.7.10 Jul 23, 2025: Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter
9.7.11 Jun 16, 2025: Wellstar Breaks Ground on New Cancer-Care Facility in Cartersville
9.7.12 Jun 12, 2025: NuvOx Announces First Patient Dosed for Extend Trials: NanO2 for Mild Respiratory Distress in Phase Ib and ARDS in Phase II Trials
9.7.13 Apr 30, 2025: Wellstar Expanding Cancer Care in Spalding County
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer